Please switch to landscape mode for the best experience.
auxo
BACK TO CASE STUDIES

Estimating Real-World Persistency and Compliance

share-iconprint-iconcopy-link-icon
Estimating Real-World Persistency and Compliance

The Challenge

A pharmaceutical company needed to forecast the launch of an upcoming oncology drug but faced the challenge of relying on clinical trial data for persistency and compliance metrics, which often did not reflect real-world scenarios.

ProcDNA's Solution

icon

Data Collection and Analysis

Collected 12 months of patient claims data and assessed the gap between consecutive claims, comparing it to a threshold (grace period) to determine persistency.

icon

Persistency and Compliance Estimation

Calculated persistency as the percentage of patients continuing therapy after a specific period, while compliance was measured by tracking the percentage of days a patient adhered to their prescribed dosage.

Impact

icon

Enhanced Sales Forecasting Accuracy

Improved forecast accuracy by up to 20%, supporting better strategic decisions.

icon

Re-evaluated Lifetime Value (LTV)

Enabled the client to re-evaluate LTV using real-world persistency and compliance data, resulting in more informed business decisions.

Related Case Studies

Partner with us

At the heart of our approach is a commitment to your success. We take time to understand your unique challenges and craft tailored solutions that drive meaningful results. Let's build something extraordinary together.